A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer. Hashimoto T, Takayanagi D, Yonemaru J, Naka T, et al. Br J Cancer 2023 Aug 5. doi: 10.1038/s41416-023-02382.

Read + Share

Amedeo Smart

Independent Medical Education

Hashimoto T, Takayanagi D, Yonemaru J, Naka T, et al. A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer. Br J Cancer 2023 Aug 5. doi: 10.1038/s41416-023-02382.
PMID: 37543670